Aerpio Pharmaceuticals, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced operating income was USD 9.256 million compared to operating loss of USD 5.979 million a year ago. Net income was USD 9.276 million compared to net loss of USD 5.684 million a year ago. Basic earnings per share from continuing operations was USD 0.23 compared to basic loss per share from continuing operations of USD 0.14 a year ago. For the half year, operating income was USD 5.141 million compared to operating loss of USD 14.820 million a year ago. Net income was USD 5.357 million compared to net loss of USD 14.176 million a year ago. Basic earnings per share from continuing operations was USD 0.13 compared to basic loss per share from continuing operations of USD 0.35 a year ago.